Drugs / Sargramostim for Injection
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT05075122 Background | Aug 2021 → Aug 2024 | head and neck squamous cell carcinoma | Martin-Luther-University Halle-Wittenberg | Unknown | Missed primary |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sargramostim for Injection | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05075122 ↗ |